Lack of access rights - File '/cache/7/d7a7f3d2371a6272e5ecdf8ef6ebc600.jpg'

Results of 62005 study available now

SPAEN Study Results 62005 04







The 62005 study looked at the ten-year progression-free and overall survival in patients with unresectable or metastatic gastrointestinal stromal tumours (GIST). Long-term analysis of the EORTC, ISG, AGITG intergroup Phase III randomized trial on imatinib at two dose levels.

Results Study 62005

Pin It